115 related articles for article (PubMed ID: 37751246)
1. Prognostic Impact of FSTL3, ADAM12, and FAT4 in Patients of Colon Cancer: Clinicopathologic Study.
Ibrahim HM; Abdelrahman AE; Elwan A; Bakry A; Fahmy MM; Abdelhamid MI; Abdelwanis AH; Fouad EM
Appl Immunohistochem Mol Morphol; 2023 Nov-Dec 01; 31(10):673-681. PubMed ID: 37751246
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Impact of LGR5, Prox1, and Notch1 Biomarkers in Stage II to III Colon Cancer.
Abdelrahman AE; El-Azony A; Elsebai E; Ibrahim HM
Appl Immunohistochem Mol Morphol; 2022 Feb; 30(2):126-135. PubMed ID: 34657081
[TBL] [Abstract][Full Text] [Related]
3. Prognostic and clinic-pathological significances of HOXB8, ILK and FAT4 expression in colorectal cancer.
Abuderman AA; Harb OA; Gertallah LM
Contemp Oncol (Pozn); 2020; 24(3):183-192. PubMed ID: 33235545
[TBL] [Abstract][Full Text] [Related]
4. Follistatin-Like 3 Enhances Invasion and Metastasis via β-Catenin-Mediated EMT and Aerobic Glycolysis in Colorectal Cancer.
Li Y; Tian M; Liu W; Wang D; Zhou Z; Pei Q; Huang Y; Tan F; Güngör C
Front Cell Dev Biol; 2021; 9():660159. PubMed ID: 34395416
[TBL] [Abstract][Full Text] [Related]
5. FAT4 silencing promotes epithelial-to-mesenchymal transition and invasion via regulation of YAP and β-catenin activity in ovarian cancer.
Malgundkar SH; Burney I; Al Moundhri M; Al Kalbani M; Lakhtakia R; Okamoto A; Tamimi Y
BMC Cancer; 2020 May; 20(1):374. PubMed ID: 32366234
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of follistatin-like 3 in human invasive breast cancer.
Couto HL; Buzelin MA; Toppa NH; Bloise E; Wainstein AJ; Reis FM
Oncotarget; 2017 Jun; 8(26):42189-42197. PubMed ID: 28178680
[TBL] [Abstract][Full Text] [Related]
7. Fat4 suppression induces Yap translocation accounting for the promoted proliferation and migration of gastric cancer cells.
Ma L; Cui J; Xi H; Bian S; Wei B; Chen L
Cancer Biol Ther; 2016; 17(1):36-47. PubMed ID: 26575609
[TBL] [Abstract][Full Text] [Related]
8. Elevation of ADAM12 facilitates tumor progression by enhancing metastasis and immune infiltration in gastric cancer.
Zhu H; Jiang W; Zhu H; Hu J; Tang B; Zhou Z; He X
Int J Oncol; 2022 May; 60(5):. PubMed ID: 35315496
[TBL] [Abstract][Full Text] [Related]
9. FAT4 functions as a tumour suppressor in gastric cancer by modulating Wnt/β-catenin signalling.
Cai J; Feng D; Hu L; Chen H; Yang G; Cai Q; Gao C; Wei D
Br J Cancer; 2015 Dec; 113(12):1720-9. PubMed ID: 26633557
[TBL] [Abstract][Full Text] [Related]
10. A pan-cancer analysis of FAT atypical cadherin 4 (FAT4) in human tumors.
Mao W; Zhou J; Hu J; Zhao K; Fu Z; Wang J; Mao K
Front Public Health; 2022; 10():969070. PubMed ID: 36051999
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of FSTL3 abates the proliferation and metastasis of renal cell carcinoma via the GSK-3β/β-catenin signaling pathway.
Sun F; Sun P; Yang X; Hu L; Gao J; Tian T
Aging (Albany NY); 2021 Sep; 13(18):22528-22543. PubMed ID: 34555811
[TBL] [Abstract][Full Text] [Related]
12. Relationship between prognostic impact of N3 lymph node metastasis at the root of the feeding artery and location of colon cancer.
Mizuuchi Y; Tanabe Y; Sada M; Tamura K; Nagayoshi K; Nagai S; Watanabe Y; Tamiya S; Ohuchida K; Nakata K; Nakano T; Nakamura M
Langenbecks Arch Surg; 2023 Jan; 408(1):31. PubMed ID: 36645515
[TBL] [Abstract][Full Text] [Related]
13. Follistatin-Like 3 Correlates With Lymph Node Metastasis and Serves as a Biomarker of Extracellular Matrix Remodeling in Colorectal Cancer.
Yang C; Cao F; Huang S; Zheng Y
Front Immunol; 2021; 12():717505. PubMed ID: 34335633
[TBL] [Abstract][Full Text] [Related]
14. The Negative Prognostic Impact of Lymph Node Skip Metastasis in Stage III Colon Cancer With pN1 Disease: A Single-Center and Retrospective Cohort Study.
Chang CY; Lin CC; Lin HH; Lan YT; Chang SC; Wang HS; Yang SH; Chen WS; Lin JK; Jiang JK
Dis Colon Rectum; 2023 Oct; 66(10):e1032-e1042. PubMed ID: 36538674
[TBL] [Abstract][Full Text] [Related]
15. Increased ADAM12 Expression Predicts Poor Prognosis in Cervical Cancer Patients before General Anesthesia.
Ma X; Wu Z; Zhang J; Shao X; Shen H
Clin Lab; 2021 Feb; 67(2):. PubMed ID: 33616346
[TBL] [Abstract][Full Text] [Related]
16. A disintegrin and metalloprotease 12 (ADAM12) is a prognostic factor in resected pathological stage I lung adenocarcinoma.
Mino N; Miyahara R; Nakayama E; Takahashi T; Takahashi A; Iwakiri S; Sonobe M; Okubo K; Hirata T; Sehara A; Date H
J Surg Oncol; 2009 Sep; 100(3):267-72. PubMed ID: 19544357
[TBL] [Abstract][Full Text] [Related]
17. ADAM metallopeptidase domain 12 overexpression correlates with prognosis and immune cell infiltration in clear cell renal cell carcinoma.
Gao J; Yang D; Xu H; Yang K; Ma J; Xia J; Pan X
Bioengineered; 2022 Feb; 13(2):2412-2429. PubMed ID: 35094638
[TBL] [Abstract][Full Text] [Related]
18. Lymph node yield in the pathological staging of resected nonmetastatic colon cancer: The more the better?
Simões P; Fernandes G; Costeira B; Machete M; Baptista C; N Silva D; Leal-Costa L; Prazeres G; Correia J; Albuquerque J; Padrão T; Gomes C; Godinho J; Faria A; Casa-Nova M; Lopes F; Teixeira JA; F Pulido C; Oliveira H; Mascarenhas-Lemos L; Albergaria D; Maio R; Passos-Coelho JL
Surg Oncol; 2022 Aug; 43():101806. PubMed ID: 35841744
[TBL] [Abstract][Full Text] [Related]
19. Association of Prognostic Value of Primary Tumor Location in Stage III Colon Cancer With RAS and BRAF Mutational Status.
Taieb J; Kourie HR; Emile JF; Le Malicot K; Balogoun R; Tabernero J; Mini E; Folprecht G; Van Laethem JL; Mulot C; Bouché O; Aparicio T; Michel P; Thaler J; Bridgewater J; Van Cutsem E; Perkins G; Lepage C; Salazar R; Laurent-Puig P;
JAMA Oncol; 2018 Jul; 4(7):e173695. PubMed ID: 29167892
[TBL] [Abstract][Full Text] [Related]
20. Serum-based measurements of stromal activation through ADAM12 associate with poor prognosis in colorectal cancer.
Ten Hoorn S; Waasdorp C; van Oijen MGH; Damhofer H; Trinh A; Zhao L; Smits LJH; Bootsma S; van Pelt GW; Mesker WE; Mol L; Goey KKH; Koopman M; Medema JP; Tuynman JB; Zlobec I; Punt CJA; Vermeulen L; Bijlsma MF
BMC Cancer; 2022 Apr; 22(1):394. PubMed ID: 35413826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
